News Sentiment

GPCR sentiment intelligence

Structure Therapeutics Inc. American Depositary Shares news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 55 Balanced news tone 53 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 53.36 Week of 10 Jul 2026
Weighted tone 55/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

84/100 classification confidence.

Company focus 45

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

-0.2% over one week, +24.3% over four weeks, trend inactive, and materially above fair value.

Latest direct headline Negative

Structure Therapeutics (NASDAQ: GPCR) CSO exercises options and sells ADS

Market Reaction

Balanced read

55/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 84/100 classification
One-week reaction -0.2% Price digesting
Trend fit Trend inactive 24.3% over four weeks
Fair value 36.5% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 16
Neutral 32
Negative 5

Relevance

Why the article matched

Direct first
Direct company coverage 45
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Market source 16
Stock Titan 8
simplywall.st 4
TradingView 4
TradingKey 4
Investing.com Canada 3
Quartr 3
GlobeNewswire 2

Event Lens

What the news is about

Classified themes
Market update 35
Earnings 11
Analyst action 6
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 53
Stock Titan Direct company coverage

Structure Therapeutics (NASDAQ: GPCR) CSO exercises options and sells ADS

Structure Therapeutics Inc.'s Chief Scientific Officer, Xichen Lin, exercised options for 23,634 Ordinary Shares, converted them into 7,878 American Depositary Shares (ADS), and subsequently sold all the ADS at weighted average prices of $50.7956 and $51.7088. These transactions

Tone
Negative 37/100
Event
Market update
Published
16 Jul 2026 23:10
Source
Stock Titan
Investing.com Canada Direct company coverage

Form 4 Structure Therapeutics Inc ADR For: 15 July By Investing.com

Investing.com has published a Form 4 for Structure Therapeutics Inc. ADR, detailing activity on July 15. The article provides the title of the SEC filing and includes general market data and related news without specifying the content of the Form 4. It also lists various financia

Tone
Neutral 50/100
Event
Market update
Published
15 Jul 2026 23:10
Source
Investing.com Canada
Quartr Direct company coverage

Structure Therapeutics (GPCR) Jefferies Global Healthcare Conference 2026 Summary

This article summarizes Structure Therapeutics' presentation at the Jefferies Global Healthcare Conference 2026, focusing on the company's progress in oral GLP-1 and Amylin therapies. It highlights the significant market shift towards oral options, impressive efficacy data for Al

Tone
Positive 74/100
Event
Market update
Published
10 Jul 2026 06:13
Source
Quartr
Quartr Direct company coverage

Structure Therapeutics (GPCR) Morgan Stanley 23rd Annual Global Healthcare Conference summary

Structure Therapeutics presented at the Morgan Stanley 23rd Annual Global Healthcare Conference, emphasizing its strategic focus on developing accessible oral medicines, particularly in the GLP-1 and amylin space. The company highlighted its lead program aleniglipron, recent FDA

Tone
Positive 81/100
Event
Market update
Published
09 Jul 2026 04:05
Source
Quartr
Stock Traders Daily Direct company coverage

(GPCR) as a Liquidity Pulse for Institutional Tactics

This article analyzes Structure Therapeutics Inc. (NASDAQ: GPCR), highlighting a strong overweight bias across all horizons. It identifies an exceptional short setup with a significant risk-reward ratio, and details three AI-generated institutional trading strategies tailored to

Tone
Positive 71/100
Event
Balance sheet
Published
07 Jul 2026 18:40
Source
Stock Traders Daily
Quartr Direct company coverage

Structure Therapeutics (GPCR) Corporate presentation Summary

Structure Therapeutics presented its corporate summary, emphasizing its mission to make oral small molecule therapeutics for chronic conditions globally accessible, particularly for obesity and related metabolic diseases. The company highlighted the significant market opportunity

Tone
Positive 93/100
Event
Market update
Published
06 Jul 2026 04:10
Source
Quartr
Stock Titan Direct company coverage

If You Invested $1,000 in Structure Therapeutics Inc ADR (GPCR)

This article analyzes the historical performance of Structure Therapeutics Inc ADR (GPCR) stock. It details that a $1,000 investment made one year ago would now be worth $2,854, showing a 185.4% total return. The company is a clinical-stage biopharmaceutical firm focusing on oral

Tone
Positive 66/100
Event
Market update
Published
04 Jul 2026 11:39
Source
Stock Titan
Finviz Direct company coverage

GPCR - Structure Therapeutics Inc ADR Options

This article provides a detailed financial overview of Structure Therapeutics Inc. (GPCR) ADR options, including its stock performance, key financial metrics, ownership details, and analyst recommendations. It highlights important data such as market cap, P/E ratio, sales, and em

Tone
Neutral 50/100
Event
Analyst action
Published
03 Jul 2026 14:10
Source
Finviz
Intellectia AI Direct company coverage

GPCR Stock News Today | Earnings, Events & Price Alerts

This article provides news and event updates for GPCR stock, including recent reports on Eli Lilly's strong performance, the future outlook for obesity drugs, and Structure Therapeutics' positive Phase 2 clinical trial results for aleniglipron. It highlights aleniglipron's effica

Tone
Positive 71/100
Event
Earnings
Published
02 Jul 2026 02:40
Source
Intellectia AI
Investing.com Canada Direct company coverage

Form 4 Structure Therapeutics Inc ADR For: 29 June By Investing.com

This article reports on a Form 4 filing for Structure Therapeutics Inc ADR, dated June 29. It is a brief announcement from Investing.com, providing basic information about the financial disclosure. The article was published on June 29, 2026, at 8:38 PM.

Tone
Neutral 50/100
Event
Market update
Published
30 Jun 2026 01:39
Source
Investing.com Canada
Stock Titan Direct company coverage

[Form 4] Structure Therapeutics Inc. Insider Trading Activity

Structure Therapeutics Inc.'s Chief Scientific Officer, Xichen Lin, reported an exercise-and-sale transaction involving American Depositary Shares (ADS) tied to the company’s Ordinary Shares. Lin exercised share options for 23,634 Ordinary Shares at $0.34 per share, which were co

Tone
Negative 40/100
Event
Market update
Published
30 Jun 2026 00:39
Source
Stock Titan
Investing.com Nigeria Direct company coverage

Form 144 Structure Therapeutics Inc. For: 25 June By Investing.com

This article from Investing.com announces the filing of Form 144 for Structure Therapeutics Inc. on June 25th. Form 144 allows affiliates of a company to sell restricted or control securities. The article provides current market data, including indices, commodities, and shares.

Tone
Neutral 50/100
Event
Market update
Published
26 Jun 2026 11:40
Source
Investing.com Nigeria
TradingView Direct company coverage

Structure Therapeutics, Inc. Sponsored ADR Actuals & Estimates (NASDAQ:GPCR)

This page on TradingView provides financial actuals and estimates for Structure Therapeutics Inc. (NASDAQ: GPCR). Users can explore reported financial data and analyst estimates across income statements, balance sheets, cash flow statements, and valuation metrics, comparing actua

Tone
Neutral 50/100
Event
Analyst action
Published
26 Jun 2026 11:09
Source
TradingView
TradingView Direct company coverage

GPCR Forecast — Price Target — Prediction for 2027

This article provides a price target forecast for Structure Therapeutics Inc. (GPCR) for 2027, based on analysis from 14 analysts. The consensus 1-year price target is $107.00. The report also mentions analyst ratings, EPS, and revenue metrics, while disclaiming that the informat

Tone
Neutral 50/100
Event
Earnings
Published
25 Jun 2026 20:12
Source
TradingView
The Globe and Mail Direct company coverage

Shareholders Approve Directors, Auditors at 2026 Meeting

Structure Therapeutics, Inc. (GPCR) held its 2026 Annual General Meeting of Shareholders, where shareholders elected Class III directors Ted W. Love, Raymond Stevens, and Daniel G. Welch to serve until the 2029 annual meeting. Ernst & Young LLP was ratified as the independent reg

Tone
Neutral 50/100
Event
Market update
Published
19 Jun 2026 21:10
Source
The Globe and Mail
Stock Titan Direct company coverage

Structure Therapeutics (GPCR) grants 39,453-share option award to director

Structure Therapeutics Inc. (GPCR) director Sharon Tetlow was granted options to acquire 39,453 Ordinary Shares. The options have an exercise price of $15.00 per share, expire on June 16, 2036, and vest in equal monthly installments over 12 months starting June 17, 2026, or immed

Tone
Neutral 50/100
Event
Market update
Published
19 Jun 2026 20:10
Source
Stock Titan
Stock Titan Direct company coverage

Structure Therapeutics (GPCR) director receives 39,453 share options at $15

Ted W. Love, a director at Structure Therapeutics Inc. (GPCR), has been granted 39,453 share options with an exercise price of $15.00 per Ordinary Share. These options will vest in equal monthly installments over the 12 months following June 17, 2026, and will be fully vested bef

Tone
Neutral 50/100
Event
Market update
Published
19 Jun 2026 08:09
Source
Stock Titan
Stock Titan Direct company coverage

Director at Structure Therapeutics (NASDAQ: GPCR) gets 39,453 options

Russell Angus C., a director at Structure Therapeutics (GPCR), has been granted options to purchase 39,453 Ordinary Shares at an exercise price of $15.00 per share. These options will vest in equal monthly installments over 12 months starting June 17, 2026, and will be fully vest

Tone
Neutral 50/100
Event
Market update
Published
18 Jun 2026 20:40
Source
Stock Titan
TradingKey Direct company coverage

Structure Therapeutics Inc (GPCR) Institutional Confidence

This article provides an overview of institutional confidence in Structure Therapeutics Inc. (GPCR), detailing major institutional shareholders and changes in their holdings. Key shareholders include Fidelity Management & Research Company LLC, Wellington Management Company, LLP,

Tone
Positive 72/100
Event
Market update
Published
17 Jun 2026 23:10
Source
TradingKey
TradingKey Direct company coverage

Structure Therapeutics Inc (GPCR) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis for Structure Therapeutics Inc (GPCR), focusing on key metrics like P/E, P/B, P/S, and P/CF ratios. As of the report, relevant data for these valuation metrics have not yet been disclosed by the company. The overview includes the company

Tone
Neutral 50/100
Event
Market update
Published
17 Jun 2026 23:10
Source
TradingKey
TradingView Direct company coverage

GPCR: Board elections, auditor ratification, and clinical milestones marked a pivotal year

Structure Therapeutics Inc. (GPCR) held its AGM where all proposals, including board elections, auditor ratification, and executive compensation, passed. The company also highlighted significant clinical progress in chronic weight management and confirmed a strong capital positio

Tone
Positive 66/100
Event
Market update
Published
17 Jun 2026 17:09
Source
TradingView
TradingKey Direct company coverage

Structure Therapeutics Inc (GPCR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article from TradingKey provides an analysis page for Structure Therapeutics Inc (GPCR), focusing on its revenue breakdown. However, the relevant data regarding business segments, regional revenue, and profit contribution have not been disclosed by the company yet. The page

Tone
Neutral 50/100
Event
Earnings
Published
17 Jun 2026 13:09
Source
TradingKey
TradingKey Direct company coverage

Structure Therapeutics Inc (GPCR) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Structure Therapeutics Inc (GPCR), identifying major institutional holders and their proportion of shares. It also breaks down shareholder types, showing dominant investment advisors and hedge funds. Additionally, the article outl

Tone
Neutral 50/100
Event
Market update
Published
17 Jun 2026 13:09
Source
TradingKey